Recurrent Thyroid Gland Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08875Cabozantinib1Active Not Recruiting1
DB08912Dabrafenib1Recruiting1
DB01259Lapatinib1Recruiting1
DB06176Romidepsin1Recruiting1
DB04849Cediranib1 / 2Active Not Recruiting1
DB00480Lenalidomide1 / 2Active Not Recruiting1
DB08916Afatinib2Recruiting1
DB08885Aflibercept2Completed1
DB08875Cabozantinib2Active Not Recruiting1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB12282Defactinib2Recruiting1
DB09078Lenvatinib2Not Yet Recruiting1
DB09035Nivolumab2Recruiting1
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting1
DB06589Pazopanib2Active Not Recruiting1
DB09037Pembrolizumab2Not Yet Recruiting1
DB06366Pertuzumab2Recruiting1
DB11689Selumetinib2Completed1
DB11689Selumetinib2Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB01268Sunitinib2Active Not Recruiting1
DB01268Sunitinib2Recruiting1
DB08911Trametinib2Recruiting2
DB05773Trastuzumab emtansine2Recruiting1
DB08828Vismodegib2Recruiting1